COLLINGWOOD, Ontario, Sept. 07, 2016 -- Isowater Corporation (Isowater), a reliable supplier of deuterium oxide (heavy water) and deuterium gas systems, is pleased to announce that Dr. Joseph P. Porwoll, a former executive of Sigma-Aldrich, has been appointed to its Board of Directors.
Dr. Porwoll joined Isowater in 2014 as Vice President of Business Development after a successful 30-year career with Aldrich Chemical Company (later Sigma-Aldrich) a world leading speciality chemical company in the life science and high tech sector. During his career with Sigma-Aldrich he served in a variety of roles including President of Aldrich Corporation and Vice President of Global Supply Chain of Sigma Aldrich where he provided corporate guidance to senior leaders of various operational functions and defined crucial strategies for improvements to supply chain execution. In addition, he developed, manufactured and managed stable isotope production systems including those with deuterium. Throughout his career Dr. Porwoll has established a broad network of contacts in the high tech, life sciences and environmental sectors. Dr. Porwoll holds a Ph.D. in Bio-Organic Chemistry from the University of Minnesota, Minneapolis. In addition to his commercial expertise and contacts, Dr. Porwoll brings extensive technical knowledge of the key markets for Isowater’s deuterium products.
Since joining Isowater, Dr. Porwoll has expanded Isowater’s business activities in the US and certain international markets. Dr. Porwoll’s addition to the Board of Directors is a further demonstration of Isowater’s commitment to meeting the needs of our customers particularly in the life sciences, including the growing pharmaceutical markets.
Andrew Stuart, President & CEO of Isowater Corporation, states, "Joe brings a wealth of technical expertise to the Board, which is critical to strategic planning and setting our overall strategic direction. Isowater is responding to increased demand for its products in both traditional markets and new emerging growth markets. Joe’s experience and technical input is critical to our success to date and to future market penetration."
Upcoming Event
15th Annual Contract Pharma 2016
Isowater’s Vice President & General Manager, A. James (Jim) Farmilo, Ph.D. and Isowater’s Vice President of Sales & Marketing, Lisa A. Stuart will be attending the 15th Annual Contract Pharma 2016 Contracting & Outsourcing Conference, Sept. 22nd & 23rd Hyatt Regency, New Brunswick, New Jersey http://conference.contractpharma.com/. To coordinate a meeting with Jim or Lisa please contact us at sales @isowater.com.
About Isowater
Isowater Corporation is a Canadian clean technology company and leading global supplier of deuterium oxide and related products for the Life Sciences, High Technology and Environmental Science sectors. Our products are deuterium oxide (heavy water; 2H20; D20) and custom solutions for deuterium gas management (heavy hydrogen gas; 2H2; D2).
Applications for Isowater’s deuterium products within the Life Sciences, High Technology and Environmental Science sectors include: Pharmaceutical, Semiconductors, Fibre Optics, Health and Beauty products, Medical Procedures, Research and Hydrology.
Isowater is supplying the needs of customers for deuterium oxide today while at the same time developing supply chain solutions that lower deuterium oxide cost through recycling. Isowater’s focus is to ensure long term stable supply to meet the needs of customers.
Contact: Wanda Cutler Director of Marketing and Communications Isowater Corporation Email: [email protected] Telephone: 416-303-6460 www.isowater.com www.linkedin.com/company/1820527 www.facebook.com/isowatercorp


Washington Post Publisher Will Lewis Steps Down After Layoffs
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 



